Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...
The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for ...
Reading death threats sent by vegan "fundamentalists" was Neil Rankin's first introduction to plant-based food. The Cordon Bleu-trained chef had just opened a nose-to-tail barbecue restaurant ...